Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TRIP13 promotes lung cancer cell growth and metastasis through AKT/mTORC1/c-Myc signaling

27 Oct 2020

Abstract excerpt

BACKGROUND: Lung adenocarcinoma (LUAD) is a primary cause of cancer-patient mortality throughout the world. Thyroid hormone receptor interactor 13 (TRIP13) is a gene that expresses a protein involved in cell division, including tumorigenesis. Its expression is high in various human tumors; however, its role in LUAD cells remains undetermined. OBJECTIVE: To investigate the TRIP13's role in the development of LUAD....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Stress, Anesthesia, and Immune Response
Share to Lung Cancer Treatments and Mutations
Share to PI3K/AKT/mTOR signaling in cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33136091
DOI: 10.3233/cbm-200039

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TRIP13 promotes lung cancer cell growth and metastasis through AKT/mTORC1/c-Myc signalingPMID 33136091Read ↗

Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4Semantic proximity Read ↗

Thyroid Hormone Receptor Interacting Protein 13 Is Associated with Prognosis and Immunotherapy Efficacy in Human Cancers: A Pan-cancer AnalysisSemantic proximity Read ↗

TRIP13 promotes proliferation and invasion of epithelial ovarian cancer cells through Notch signaling pathway.Semantic proximity Read ↗

TRIP13 Activates the PI3K/AKT Signal Pathway to Promote Melanoma Progression by Interacting With FLNASemantic proximity Read ↗

Insights into a Crucial Role of TRIP13 in Human CancerSemantic proximity Read ↗

LEM domain containing 1 promotes thyroid cancer cell proliferation and migration by activating the Wnt/β‑catenin signaling pathway and epithelial‑mesenchymal transitionSemantic proximity Read ↗

TRIP13 promotes metastasis of colorectal cancer regardless of p53 and microsatellite instability status.Semantic proximity Read ↗

The oncogenic E3 ligase TRIP12 suppresses epithelial–mesenchymal transition (EMT) and mesenchymal traits through ZEB1/2Semantic proximity Read ↗

Role of TELO2-interacting protein 1(TTI1) functions as an oncogene by regulating mTOR activity in the progression of non-small cell lung cancerSemantic proximity Read ↗

Phospholipase C Delta 3 inhibits apoptosis and promotes proliferation, migration, and invasion of thyroid cancer cells via Hippo pathwaySemantic proximity Read ↗

LncRNA-mediated High Expression of TRIP13 Correlates with Poor Prognosis and Tumor Immune Infiltration of Hepatocellular CarcinomaSemantic proximity Read ↗

The oncogenic E3 ligase TRIP12 suppresses epithelial-mesenchymal transition (EMT) and metastasis-related processes through ZEB1/2Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.